Best Physicians Immunology Marseille Near Me

4worldlovers:
Thirumala-Devi KANNEGANTI - St Jude Children’s research Hospital, Memphis, USA

David HUME - Mater Research Institute-University of Queensland, Translational Research Institute, AUS


The P. PIERRE ’s team is happy to be part of the IMMERGE project, “Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches”. This project is a Marie…


Every year, in order to reward the excellence of research work carried out during…

A Junior Professor Chair, a new way of recruiting on the basis of research and teaching projects, has been opened…

An Inserm team at the Marseille-Luminy Immunology Center has identified the earliest mutations involved in the development of follicular lymphoma, a rare blood cancer. In about a third of patients, the researchers have identified two genetic alterations that drive the cells into a pathological state, almost ten years before the onset of symptoms. This meticulous work is leading to a better understanding of this hematological cancer, and opens the way to new therapeutic avenues to intervene early and avoid relapse in a large number of cases.

Correct immune system function depends on the continuous supply of white blood cells derived from stem cells that reside in the bone marrow. These are known as blood stem cells or hematopoietic stem cells. Researchers from Inserm, CNRS and Université d’Aix-Marseille at the Center of Immunology Marseille-Luminy have now discovered a new role played by these cells in immune response.

EMBO announces 24 scientists as the newest members of the EMBO Young Investigator Programme. The programme supports excellent group leaders who have been in independent positions for less than four years and have an excellent track record of scientific achievements.

The new EMBO Young Investigators will join the existing network of 135 current and 390 former members of the programme. They will receive financial and practical support for a period of four years, starting in January 2023.

4worldlovers: Veracyte helps translate the complex tumor immune response into a clear path forward for our biopharma partners. We offer customized biomarker testing and analytical services to help them advance their therapeutic discovery, development and commercialization programs.